Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02632552 · ClinicalTrials.gov registry record · NA
A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD
A NA study of COPD and CHF, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 5
- Study locations
NCT02632552 is a NA study of COPD and CHF that has completed, run by VA Office of Research and Development. The registered enrollment target is 140 participants, below the 2,417-participant average among 85 other COPD trials with a reported enrollment target (94% lower). The trial reports 5 study locations across 4 states.
The verdict
NCT02632552, a NA study of COPD and CHF, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 5
- Study locations
Study Summary
Transition from hospital to home places patients in jeopardy of adverse events and increases their risk for rehospitalization. CHF is the most prevalent chronic condition among U.S. adults and COPD is the third leading cause of death in the U.S. Both CHF and COPD represent significant burdens for the VHA healthcare system. Care transitions can be supported through multi-component interventions, but are costly to implement. Virtual nurses provide an effective medium for explaining health concepts to patients, and previous work indicates patients find virtual nurses acceptable. The investigators will implement and evaluate a virtual nurse intervention to provide automated, tailored, and timely support to Veterans transitioning from hospital to home. As effective care transition interventions incorporate both inpatient and outpatient components, the virtual nurse will first engage with patient onscreen during their inpatient stay and then via text message post-discharge. This project has the potential to improve the care transition experience for patients, caregivers and healthcare providers.
Interventions
- BEHAVIORAL Technology-assisted care transition intervention
- BEHAVIORAL Active attention control
Study Locations (5)
Massachusetts
- VA Bedford HealthCare System, Bedford, MA - Bedford
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
Illinois
- Edward Hines Jr. VA Hospital, Hines, IL - Hines
Iowa
- Iowa City VA Health Care System, Iowa City, IA - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2021-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02632552
The ClinicalTrials.gov registry entry for NCT02632552 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,417-participant average among 85 other COPD trials with a reported enrollment target (94% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with COPD appearing as the primary indexed condition, and to 2 interventions - of which Technology-assisted care transition intervention is the first listed.
NCT02632552 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Massachusetts, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT02632552 about?
NCT02632552 is a clinical study titled "A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD". Transition from hospital to home places patients in jeopardy of adverse events and increases their risk for rehospitalization. CHF is the most prevalent chronic condition among U.S. adults and COPD is the third leading cause of death in the U.S. Both CHF and COPD represent significant burdens for th...
What is the current status of trial NCT02632552?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2018-05-01. Estimated completion is 2021-08-31.
What conditions does trial NCT02632552 study?
This clinical trial studies the following conditions: COPD, CHF.
What interventions are being tested in trial NCT02632552?
The interventions under investigation include: Technology-assisted care transition intervention (BEHAVIORAL), Active attention control (BEHAVIORAL).
Who is sponsoring clinical trial NCT02632552?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02632552 being conducted?
This trial has 5 study locations across California, Illinois, Iowa, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
The Reducing REVISITS Study: A Cluster RCT
RECRUITING · NA
-
The Effect of a Technology-Mediated Integrated Walking and Tai Chi Intervention on Physical Function in Veterans With COPD and Chronic Musculoskeletal Pain
RECRUITING · NA
-
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.